News and Announcements

Apr 4, 2013 by Denver Business Journal

Rancher and philanthropist Sue Anschutz-Rodgers has donated $2 million toward creating an endowed chair in retinal diseases which will be held by Naresh Mandava, MD.

Dec 31, 2012 by Davis Partnership Architects

The original 47,000 sqft building was designed by Davis Partnership Architects around 2001. This addition adds another 85,000 square feet with another 10,000 square feet of remodeled space.

Aug 20, 2012 by Wyoming News

Elly has been diagnosed with familial exudative vitreoretinopathy, or FEVR for short. Dr. Scott Oliver diagnosed her at Children’s Hospital Colorado.

Mar 20, 2012 by CU Denver Today

ACPE’s Board of Directors honored Enzenauer as a Fellow for demonstrating significant and enduring contributions to the advancement of medical management.

Aug 22, 2011 by CU Anschutz Today

Malik Kahook, MD, showed visitors how unique polymers can be inserted into tiny incisions in the eye and then, after being exposed to the ocular environment, be used to deliver drugs to treat glaucoma.

Dec 13, 2011 by UCH Insider

It’s the first new technique for removing cataracts in roughly three decades. Physicians at the UCHealth Eye Center became the first in the metro area to start using it.

Nov 9, 2010 by CU Anschutz Today

A study shows that unsupervised children are most at risk for bites, that the culprits are usually family pets and if they bite once, they will bite again with the second attack often more devastating than the first.

Aug 27, 2010 by CU Anschutz Today

In his quest to save eyesight in patients with ocular cancer, Scott Oliver, MD, discovered that silicone oil could block radiation from striking critical structures while allowing it to hit the tumor.

Mar 1, 2010 by EyeWorld News

Darren Gregory, MD, sees success using amniotic membrane to treat ocular problems in Stevens-Johnson Syndrome.

Jan 1, 2010 by The Diabetes Magazine

J. Mark Petrash, PhD, is Professor and Vice Chair of Research in the Department of Ophthalmology at the University of Colorado School of Medicine and is a leader in the field of aldose reductase research.

Dec 31, 2008 by Glaucoma Today

Kara Hanson, OD, FAAO, Director of Low Vision Rehabilitation, discusses the ins and outs of low vision rehabilitation.

Sep 20, 2017 by Nature Communications

Optical tissue clearing has revolutionized researchers’ ability to perform fluorescent measurements of molecules, cells, and structures within intact tissue.

Sep 13, 2017 by Eye Research

On September 13, AEVR’s Decade of Vision 2010-2020 Initiative hosted its Third Annual Emerging Vision Scientists Day on Capitol Hill, which was supported by a grant from Research to Prevent Blindness.

Sep 4, 2017 by The Company of Biologists

The advent of stem cell-derived retinal organoids has brought forth unprecedented opportunities for developmental and physiological studies, while presenting new therapeutic promise for retinal degenerative diseases.

Aug 30, 2017 by CU Anschutz Today

Canto-Soler joins Ophthalmology and Gates Center for Regenerative Medicine team to develop cell-based treatments

Jul 22, 2017 by PLoS One

The mouse retina comprises seven major cell types that exist in differing proportions. They are generated from multipotent progenitors in a stochastic manner, such that the relative frequency of any given type generated changes over time.

Jul 1, 2017 by OftalmologoalDia

Interview with Dr. Canto-Soler on retinal tissue derived from stem cells (in Spanish).

Feb 1, 2017 by IOVS

How retinal bipolar cell interneurons are specified and assigned to specialized subtypes is only partially understood. In part, this is due to a lack of early pan- and subtype-specific bipolar cell markers.

Jun 23, 2014 by National Institutes of Health

Researchers induced human stem cells to create a 3-D retina structure that responds to light. The finding may aid the study of eye diseases and could eventually lead to new therapies.